Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments

Author： Kang Young Sun Cha Jin Joo Hyun Young Youl Cha Dae Ryong

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.6, 2011-06, pp. : 745-756

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Progress in the discovery of CC chemokine receptor 2 antagonists, 2009 – 2012

By Carter Percy H

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 549-568

Informa Healthcare

Access to resources Recommend Favorite

A2B Adenosine Receptor Antagonists: Recent Developments

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 12, 2005-12 ,pp. : 1053-1060

Bentham Science Publishers

Access to resources Recommend Favorite

Novel pyrimidine-based CXCR2 chemokine receptor antagonists

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 10, 2004-10 ,pp. : 1507-1510

Informa Healthcare

Access to resources Recommend Favorite

3D-Pharmacophere Models for CC Chemokine Receptor 1 Antagonists

Medicinal Chemistry, Vol. 5, Iss. 4, 2009-07 ,pp. : 318-324

Bentham Science Publishers

Access to resources Recommend Favorite

Recent developments in the field of A 2A and A 3 adenosine receptor antagonists

By Baraldi P.G. Tabrizi M.A. Bovero A. Avitabile B. Preti D. Fruttarolo F. Romagnoli R. Varani K. Borea P.A.

European Journal of Medicinal Chemistry, Vol. 38, Iss. 4, 2003-04 ,pp. : 367-382

Elsevier

Access to resources Recommend Favorite